Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to demonstrate that a single anticoagulant therapy is
superior to a combination of anticoagulant and antiplatelet therapy on the net clinical
benefit estimated at 12 months after a Transcatheter Aortic Valve Intervention (TAVI)
according to BARC2 criteria (bleeding complications; Mehran et al 2011) and VARC2 (other
complications; Kappetein et al 2012)..